MSB 2.89% $1.25 mesoblast limited

Some responses from the Yahoo board:Richard XII7 hours agoGood...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,215 Posts.
    lightbulb Created with Sketch. 951
    Some responses from the Yahoo board:

    • 7 hours ago
      Good post Stockrock. My view is that if Mesoblast discover a therapy that reduces deaths from heart failure by 60 percent and the stock tanks then management will have great difficulty staying in charge of the company. This issue adds to the FDA rejection of another effective therapy just a few months ago.

    • Martin
      9 hours ago
      well thought out and written. Thankyou

    • grossren1
      22 hours ago
      3 or 4 IMHO thanks for intelligent thoughts- couldn’t agree more-- thought trial results epic funny how mrkt misread—60% reduction mortality and MACE—epic and unparalleled

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.